GSDMB mRNA levels differed significantly between the clinical stages of six types of cancer, namely BLCA, COAD, KIRC, LUAD, pancreatic adenocarcinoma (PAAD), and rectum adenocarcinoma (READ) (Figure 3C). This evidence concerns the gene GSDMB and bladder transitional cell carcinoma.